37
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Is Implementation of the 5 A's of Smoking Cessation at Community Mental Health Centers Effective for Reduction of Smoking by Patients with Serious Mental Illness?

, MD, MPH, , PhD, , PhD, , PhD, , PharmD, PhD, , PhD, , MS, , BS, , PhD, , MD & , MS show all
Pages 386-392 | Received 13 Feb 2009, Accepted 17 Mar 2009, Published online: 29 Oct 2009

REFERENCES

  • U.S. Department of Health and Human Services. The health effects of active smoking: A report of the Surgeon General. Washington, DC: U.S. Government Printing Office; 2004.
  • Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung cancer risk. JAMA. 2005;294:1505–1510.
  • de Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res. 2005;76:135–157.
  • Lasser K, Boyd JW, Woolhander S, Himmelstein D, McCormick D, Bor DH. Smoking and mental illness: A population-based prevalence study. JAMA. 2000;284:2606–2610.
  • Waxmonsky JA, Thomas MR, Miklowitz DJ, Prevalence and correlates of tobacco use in bipolar disorder: Data from the first 2000 participants in the systematic treatment enhancement program. Gen Hosp Psychiatry. 2005;27:321–328.
  • Fagerstrom K, Aubin HJ. Management of smoking cessation in patients with psychiatric disorders. Curr Med Res Opin. 2009;25:511–518.
  • Ziedonis D, Hitsman B, Beckham JC, Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res. 2008;10:1691–1715.
  • George TP, Vessicchio JC, Sacco KA, A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia. Biol Psychiatry. 2008;63:1092–1096.
  • Baker A, Richmond R, Haile M, A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. Am J Psychiatry. 2006;163:1934–1942.
  • Thorndike AN, Stafford RS, Rigotti NA. US physicians' treatment of smoking in outpatients with psychiatric diagnoses. Nicotine Tob Res. 2001;3:85–91.
  • Lucksted A, Dixon LB, Sembly JB. A focus group pilot study of tobacco smoking among psychosocial rehabilitation clients. Psychiatr Serv. 2000;51:1544–1548.
  • Carosella AM, Ossip-Klein DJ, Owens CA. Smoking attitudes, beliefs, and readiness to change among acute and long term care inpatients with psychiatric diagnoses. Addict Behav. 1999;24:331–344.
  • Drake RE, Mercer-McFadden C, Mueser KT, McHugo GJ, Bond GR. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophr Bull. 1998;24:589–608.
  • Hellerstein DJ, Rosenthal RN, Miner CR. Integrating services for schizophrenia and substance abuse. Psychiatr Q. 2001;72:291–306.
  • Fiore MC, Bailey WC, Cohen SJ, Treating tobacco use and dependence: Clinicalpractice guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2000.
  • Fiore MC, Jaen CR, Baker TB, Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service; 2008.
  • Dixon L, Medoff D, Wohlheiter K, Correlates of smoking severity among persons with serious mental illness. Am J Addict. 2007;16:101–110.
  • US Department of Health and Human Services, National Center for Health Statistics. Third U.S. National Health and Nutrition Examination Survey (NHANES III), 1988–1994 Hyattsville, Md: Dept of Health and Human Services; 1996.
  • Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom tolerance questionnaire. Br J Addict. 1991;86:1119–1127.
  • Bedfont Scientific U. EC50 Microl III Smokerlyzer Breath Carbon Monoxide Monitor. Medford, New Jersey, USA.
  • Jarvis MJ, Russell MA, Saloojee Y. Expired air carbon monoxide: A simple breath test of tobacco smoke intake. BMJ. 1980;281:484–485.
  • Ewing JA. Detecting alcoholism: The CAGE questionnaire. JAMA. 1984;252:1905–1907.
  • Mayfield D, McLeod G, Hall P. The CAGE questionnaire: Validation of a new alcoholism screening instrument. Am J Psychiatry. 1974;10:1121–1123.
  • Hays RD, Merz JF, Nicholas R. Response burden, reliability, and validity of the CAGE, short MAST, and AUDIT alcohol screening measures. Behav Res Methods Instrum Comput. 1995;27:277–280.
  • Perkins D, Stroup TS, Lieberman JA. Assessment of psychotic disorders. In: Rush AJ, Pincus HA, First MB, , eds. American Psychiatric Association Handbook of psychiatric measures, Washington, DC: American Psychiatric Association Press, 2000:485–513.
  • Cohen S, Kamarack T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385–396.
  • Scacapan S, Oskamp S, Cohen S, Wlliamson G. Perceived stress in a probability sample of the United States. In: Anonymous, ed. The social psychology of health. Newbury Park, CA: Sage; 1988: 31–67.
  • SAS 9.1.3; SAS Institute Inc. Cary, NC, USA.
  • Fitzmaurice GM, Laird NM, Ware JH. Applied longitudinal analysis. New York: Wiley; 2004.
  • Health Services/Technology Assessment Text AHRQ Technical Reviews and Summaries, AHCPR Supported Clinical Practice Guidelines, Quick Reference Guide, Consumer Guides (English), Consumer Guides (Spanish), AIDSInfo, AHCPR Supported Clinical Practice Guidelines,18. Treating Tobacco Use and Dependence: 2008 Update, Tables, Table 6.5. Available at (http://www.ncbi.nlm.nih.gov/books/bv.fcg?rid-hstat2.table.29539) Accessed on February 8, 2009.
  • Health Services/Technology Assessment Text AHRQ Technical Reviews and Summaries, AHCPR Supported Clinical Practice Guidelines, Quick Reference Guide, Consumer Guides (English), Consumer Guides (Spanish), AIDSInfo, AHCPR Supported Clinical Practice Guidelines, 18. Treating Tobacco Use and Dependence: 2008 Update, Tables, Table 6.7. Available at (http://www.ncbi.nlm.nih.gov/books/bv.fcg?rid-hstat2.table.295341) Accessed on February 8, 2009.
  • McEvoy J, Freudenreich O, McGee M, VanderZwaag C, Levin E, Rose J. Clozapine decreases smoking in patients with chronic schizophrenia. Biol Psychiatry. 1995;37:550–552.
  • George TP, Ziedonis DM, Feingold A, Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry. 2000;157:1835–1842.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.